Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel (Q39191770)

9 September 2017

Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel (English)

1 reference

9 September 2017

Hao Wu

1

1 reference

9 September 2017

Min Huang

2

1 reference

9 September 2017

Mingjie Lu

3

1 reference

9 September 2017

Wei Zhu

4

1 reference

9 September 2017

Yongqian Shu

5

1 reference

9 September 2017

Peng Cao

6

1 reference

9 September 2017

Ping Liu

7

1 reference

9 September 2017

20 February 2013

1 reference

Cancer Chemotherapy and Pharmacology

9 September 2017

1 reference

9 September 2017

71

1 reference

9 September 2017

5

1 reference

9 September 2017

1159-1171

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-013-2108-y

9 September 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

The role of Tau protein in resistance to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Role of microRNA in anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

MicroRNA and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Implication of microRNAs in drug resistance for designing novel cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

MiR-34 and SNAIL: another double-negative feedback loop controlling cellular plasticity/EMT governed by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Practical Aspects of microRNA Target Prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Microtubule active agents: beyond the taxane frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Epigenetic regulation of miRNA genes in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Regulation of pri-miRNA Processing Through Smads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

p53 and microRNA-34 are suppressors of canonical Wnt signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2108-Y

10.1007/S00280-013-2108-Y

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference